Care Access Research-Lumberton

Lumberton, North Carolina 28358

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Primary Biliary Cholangitis, Ulcerative Colitis

Studies at this site

• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed